| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 31 | 2023 | 724 | 5.760 |
Why?
|
| Lupus Nephritis | 13 | 2023 | 78 | 4.340 |
Why?
|
| Receptors, Antigen, B-Cell | 17 | 2022 | 113 | 4.070 |
Why?
|
| Germinal Center | 6 | 2023 | 55 | 2.690 |
Why?
|
| Precursor Cells, B-Lymphoid | 6 | 2023 | 27 | 2.280 |
Why?
|
| Immunity, Humoral | 5 | 2021 | 67 | 1.840 |
Why?
|
| Lymphopoiesis | 6 | 2019 | 48 | 1.650 |
Why?
|
| Kidney | 9 | 2023 | 1241 | 1.530 |
Why?
|
| Cyclin D3 | 7 | 2018 | 20 | 1.490 |
Why?
|
| Nephritis, Interstitial | 3 | 2016 | 47 | 1.460 |
Why?
|
| Chromatin | 5 | 2023 | 380 | 1.370 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 2019 | 96 | 1.360 |
Why?
|
| Inflammation | 8 | 2022 | 920 | 1.360 |
Why?
|
| Signal Transduction | 13 | 2023 | 3241 | 1.340 |
Why?
|
| Immunoglobulin Variable Region | 4 | 2018 | 109 | 1.250 |
Why?
|
| Carrier Proteins | 4 | 2018 | 673 | 1.210 |
Why?
|
| Immunoglobulins | 3 | 2015 | 148 | 1.190 |
Why?
|
| Mice | 36 | 2023 | 11352 | 1.110 |
Why?
|
| Endocytosis | 5 | 2017 | 177 | 1.070 |
Why?
|
| Animals | 46 | 2023 | 26582 | 1.050 |
Why?
|
| Autoantibodies | 5 | 2021 | 267 | 0.990 |
Why?
|
| Cell Differentiation | 11 | 2023 | 1458 | 0.930 |
Why?
|
| Endosomes | 4 | 2017 | 75 | 0.900 |
Why?
|
| Adaptive Immunity | 4 | 2019 | 164 | 0.880 |
Why?
|
| Recombination, Genetic | 5 | 2022 | 439 | 0.880 |
Why?
|
| Agammaglobulinemia | 2 | 2018 | 20 | 0.840 |
Why?
|
| CD79 Antigens | 5 | 2017 | 17 | 0.830 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 479 | 0.800 |
Why?
|
| Antigen Presentation | 5 | 2022 | 209 | 0.780 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2022 | 158 | 0.770 |
Why?
|
| Allografts | 1 | 2021 | 172 | 0.750 |
Why?
|
| Cellular Microenvironment | 1 | 2020 | 27 | 0.740 |
Why?
|
| Dendritic Cells | 3 | 2022 | 425 | 0.730 |
Why?
|
| Pre-B Cell Receptors | 3 | 2019 | 8 | 0.730 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 193 | 0.720 |
Why?
|
| Receptors, Interleukin-7 | 4 | 2019 | 28 | 0.720 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2023 | 69 | 0.720 |
Why?
|
| Ubiquitination | 2 | 2017 | 67 | 0.700 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 44 | 0.700 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 14 | 0.690 |
Why?
|
| Cell Cycle | 2 | 2012 | 502 | 0.690 |
Why?
|
| Antigens, CD | 4 | 2002 | 458 | 0.670 |
Why?
|
| STAT5 Transcription Factor | 4 | 2019 | 42 | 0.670 |
Why?
|
| RNA Polymerase II | 1 | 2018 | 55 | 0.670 |
Why?
|
| Gene Expression Regulation | 8 | 2023 | 1920 | 0.670 |
Why?
|
| Autoantigens | 2 | 2020 | 127 | 0.660 |
Why?
|
| Machine Learning | 1 | 2020 | 232 | 0.660 |
Why?
|
| Lymphocytes | 3 | 2016 | 464 | 0.640 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 14 | 0.630 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 1195 | 0.620 |
Why?
|
| Graft Rejection | 2 | 2021 | 1065 | 0.620 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 509 | 0.600 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 849 | 0.590 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2019 | 40 | 0.560 |
Why?
|
| Cell Proliferation | 5 | 2023 | 1578 | 0.550 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 38 | 0.540 |
Why?
|
| Cell Nucleus | 3 | 2019 | 579 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 189 | 0.530 |
Why?
|
| Vimentin | 1 | 2014 | 44 | 0.510 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 132 | 0.510 |
Why?
|
| Mice, Knockout | 11 | 2020 | 1924 | 0.500 |
Why?
|
| Inflammasomes | 1 | 2014 | 23 | 0.490 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 1135 | 0.480 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 696 | 0.480 |
Why?
|
| Apoptosis | 2 | 2016 | 1683 | 0.450 |
Why?
|
| Ubiquitin | 2 | 2017 | 93 | 0.440 |
Why?
|
| Humans | 32 | 2023 | 86643 | 0.440 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2020 | 86 | 0.400 |
Why?
|
| Interferon Regulatory Factors | 3 | 2022 | 67 | 0.390 |
Why?
|
| Cicatrix | 1 | 2011 | 63 | 0.390 |
Why?
|
| Phospholipids | 1 | 2011 | 111 | 0.390 |
Why?
|
| Phosphoproteins | 2 | 2002 | 254 | 0.380 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2015 | 20 | 0.380 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 154 | 0.380 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 153 | 0.370 |
Why?
|
| Kidney Tubules | 1 | 2010 | 94 | 0.370 |
Why?
|
| Kidney Diseases | 1 | 2014 | 418 | 0.370 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 456 | 0.370 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 388 | 0.370 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 579 | 0.360 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2021 | 206 | 0.360 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 268 | 0.360 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2023 | 295 | 0.350 |
Why?
|
| Palatine Tonsil | 2 | 2021 | 30 | 0.350 |
Why?
|
| Clonal Anergy | 1 | 2009 | 30 | 0.340 |
Why?
|
| ras Proteins | 1 | 2009 | 128 | 0.330 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 2020 | 131 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 3092 | 0.320 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 1384 | 0.300 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 376 | 0.300 |
Why?
|
| Interleukin-7 | 3 | 2020 | 41 | 0.290 |
Why?
|
| Phosphorylation | 5 | 2020 | 1106 | 0.280 |
Why?
|
| Base Sequence | 5 | 2020 | 2330 | 0.270 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2021 | 1204 | 0.250 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2017 | 35 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 120 | 0.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2006 | 302 | 0.240 |
Why?
|
| Cells, Cultured | 5 | 2019 | 2818 | 0.240 |
Why?
|
| Computational Biology | 2 | 2020 | 528 | 0.240 |
Why?
|
| Flow Cytometry | 3 | 2012 | 679 | 0.220 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 78 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2012 | 28 | 0.220 |
Why?
|
| DNA Damage | 2 | 2023 | 366 | 0.220 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 78 | 0.220 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 428 | 0.220 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2022 | 17 | 0.210 |
Why?
|
| V(D)J Recombination | 2 | 2018 | 10 | 0.200 |
Why?
|
| Gene Ontology | 1 | 2021 | 34 | 0.200 |
Why?
|
| Clone Cells | 3 | 2023 | 213 | 0.200 |
Why?
|
| Adolescent | 4 | 2018 | 8981 | 0.200 |
Why?
|
| Down-Regulation | 2 | 2015 | 504 | 0.200 |
Why?
|
| Cell Plasticity | 1 | 2021 | 8 | 0.200 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1753 | 0.200 |
Why?
|
| Mammals | 1 | 2023 | 227 | 0.200 |
Why?
|
| Cells | 1 | 2021 | 32 | 0.200 |
Why?
|
| Transcriptional Activation | 2 | 2020 | 280 | 0.200 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 37 | 0.190 |
Why?
|
| Microscopy | 1 | 2021 | 87 | 0.190 |
Why?
|
| Immunoblotting | 2 | 2012 | 268 | 0.190 |
Why?
|
| Organ Specificity | 1 | 2021 | 258 | 0.190 |
Why?
|
| Protein Binding | 4 | 2020 | 1456 | 0.190 |
Why?
|
| Antibody Formation | 1 | 2021 | 171 | 0.190 |
Why?
|
| Genome | 1 | 2023 | 372 | 0.190 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 196 | 0.190 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 203 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 425 | 0.180 |
Why?
|
| Plasma Cells | 3 | 2023 | 80 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 134 | 0.180 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 37 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 316 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2022 | 1565 | 0.180 |
Why?
|
| Antigen-Antibody Complex | 2 | 2016 | 87 | 0.180 |
Why?
|
| Autoimmunity | 2 | 2023 | 160 | 0.180 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 63 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2011 | 165 | 0.170 |
Why?
|
| Proteome | 1 | 2020 | 124 | 0.170 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2016 | 22 | 0.170 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 996 | 0.170 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 72 | 0.170 |
Why?
|
| Proteomics | 1 | 2020 | 212 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 298 | 0.160 |
Why?
|
| Male | 7 | 2022 | 40965 | 0.160 |
Why?
|
| Spleen | 3 | 2009 | 430 | 0.160 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 15 | 0.160 |
Why?
|
| Cyclins | 2 | 2009 | 82 | 0.160 |
Why?
|
| Adenosine | 1 | 2020 | 225 | 0.150 |
Why?
|
| Receptors, Antigen | 1 | 2017 | 11 | 0.150 |
Why?
|
| Cyclin D2 | 2 | 2013 | 19 | 0.150 |
Why?
|
| Mice, Inbred NZB | 1 | 2016 | 13 | 0.150 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 92 | 0.150 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 20 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 217 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1621 | 0.150 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3030 | 0.150 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 35 | 0.150 |
Why?
|
| Bone Marrow | 2 | 2019 | 435 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 547 | 0.140 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 76 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 266 | 0.140 |
Why?
|
| Young Adult | 3 | 2014 | 5976 | 0.140 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 123 | 0.140 |
Why?
|
| Methylation | 2 | 2020 | 251 | 0.140 |
Why?
|
| RNA | 1 | 2020 | 560 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 927 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 296 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 1047 | 0.140 |
Why?
|
| Transcriptome | 1 | 2020 | 580 | 0.130 |
Why?
|
| Biopsy | 2 | 2021 | 1163 | 0.130 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 144 | 0.130 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 2062 | 0.130 |
Why?
|
| Interferons | 1 | 2015 | 133 | 0.130 |
Why?
|
| Alleles | 1 | 2018 | 1128 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 425 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 557 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2015 | 79 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1540 | 0.130 |
Why?
|
| Adult | 4 | 2018 | 25648 | 0.130 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 134 | 0.130 |
Why?
|
| Genomics | 1 | 2020 | 720 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2016 | 300 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1376 | 0.120 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2014 | 22 | 0.120 |
Why?
|
| Amino Acid Motifs | 2 | 2006 | 116 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 43 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 188 | 0.120 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 1208 | 0.120 |
Why?
|
| Female | 6 | 2022 | 44532 | 0.120 |
Why?
|
| Child | 2 | 2018 | 6927 | 0.120 |
Why?
|
| Antibodies, Antinuclear | 2 | 2015 | 83 | 0.120 |
Why?
|
| Biomarkers | 1 | 2020 | 1718 | 0.120 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2006 | 19 | 0.120 |
Why?
|
| Interleukins | 1 | 2014 | 134 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 154 | 0.120 |
Why?
|
| Cell Communication | 1 | 2014 | 194 | 0.110 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 170 | 0.110 |
Why?
|
| Trans-Activators | 2 | 2010 | 429 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2012 | 13 | 0.110 |
Why?
|
| Binding Sites | 2 | 2015 | 1098 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 262 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 712 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2012 | 96 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2008 | 645 | 0.110 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 53 | 0.100 |
Why?
|
| Binding, Competitive | 1 | 2011 | 145 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.100 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2011 | 30 | 0.100 |
Why?
|
| COS Cells | 1 | 2011 | 166 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 536 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 339 | 0.100 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2010 | 20 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2011 | 369 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2010 | 25 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1805 | 0.090 |
Why?
|
| United States | 1 | 2022 | 6672 | 0.090 |
Why?
|
| Mutation | 3 | 2011 | 3968 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 72 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 41 | 0.090 |
Why?
|
| Histones | 1 | 2011 | 311 | 0.090 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2009 | 10 | 0.090 |
Why?
|
| Time Factors | 2 | 2009 | 5210 | 0.090 |
Why?
|
| Antigens, Ly | 1 | 2009 | 37 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2002 | 1286 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 853 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2008 | 372 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 115 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 13 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1801 | 0.080 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2008 | 16 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2009 | 172 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 1041 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 272 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 113 | 0.080 |
Why?
|
| Cell Line | 3 | 2015 | 2468 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 199 | 0.080 |
Why?
|
| Ligands | 1 | 2009 | 433 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2009 | 692 | 0.080 |
Why?
|
| Protein Transport | 1 | 2009 | 411 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 879 | 0.080 |
Why?
|
| Cell Movement | 1 | 2010 | 758 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 689 | 0.070 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 2006 | 4 | 0.070 |
Why?
|
| Biological Transport | 1 | 2007 | 396 | 0.070 |
Why?
|
| Monophenol Monooxygenase | 1 | 2006 | 9 | 0.070 |
Why?
|
| Phospholipase C gamma | 2 | 2006 | 15 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2006 | 10 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 165 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1673 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2006 | 144 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2005 | 273 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 2006 | 249 | 0.070 |
Why?
|
| Cell Survival | 2 | 2023 | 969 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2011 | 2767 | 0.060 |
Why?
|
| Infant | 1 | 2010 | 3046 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3640 | 0.060 |
Why?
|
| CCCTC-Binding Factor | 1 | 2023 | 18 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2010 | 3612 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2006 | 666 | 0.060 |
Why?
|
| Actins | 1 | 2006 | 451 | 0.060 |
Why?
|
| Syk Kinase | 1 | 2002 | 6 | 0.050 |
Why?
|
| Type C Phospholipases | 1 | 2002 | 28 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 9 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 20 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 29 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2002 | 28 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 32 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 696 | 0.050 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2002 | 21 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2002 | 44 | 0.050 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2002 | 42 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2008 | 1196 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2002 | 80 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2022 | 146 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2426 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 341 | 0.050 |
Why?
|
| Allergens | 1 | 2022 | 179 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2022 | 152 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2022 | 187 | 0.050 |
Why?
|
| Genes, Immunoglobulin | 1 | 2002 | 111 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2019 | 728 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2022 | 252 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 271 | 0.050 |
Why?
|
| Cell Size | 1 | 2020 | 65 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 302 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2021 | 165 | 0.050 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2019 | 4 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 379 | 0.040 |
Why?
|
| Myoglobin | 1 | 1999 | 29 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 166 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1749 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 177 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 182 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7993 | 0.040 |
Why?
|
| Cytoplasm | 1 | 1999 | 281 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 378 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 246 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 1999 | 460 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2017 | 109 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 104 | 0.040 |
Why?
|
| Phenotype | 1 | 2023 | 2378 | 0.040 |
Why?
|
| Proteins | 1 | 2002 | 777 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 1170 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 559 | 0.040 |
Why?
|
| Phagosomes | 1 | 2015 | 39 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2015 | 85 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 267 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 52 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 937 | 0.030 |
Why?
|
| Hypoxia | 1 | 2020 | 641 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 265 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 1230 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 1981 | 0.030 |
Why?
|
| Tyrosine | 2 | 2006 | 133 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 36 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 66 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 85 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 23 | 0.030 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 32 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 776 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2010 | 66 | 0.020 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2008 | 20 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2008 | 20 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 75 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 256 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 322 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 381 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 229 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 576 | 0.020 |
Why?
|
| Immunoglobulin Joining Region | 1 | 2002 | 13 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2002 | 24 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 94 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 72 | 0.010 |
Why?
|
| Valine | 1 | 2002 | 69 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 86 | 0.010 |
Why?
|
| Glycine | 1 | 2002 | 92 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 80 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 279 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1156 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 246 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 253 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 736 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 171 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 1999 | 129 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 292 | 0.010 |
Why?
|